Radioembolization (Y90)
Sort by:
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: The LEGACY Study
- 124 views
- November 13, 2020
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere as a Neoadjuvant or Standalone Therapy in Treating HCC
Oct. 19, 2020
Faculty:
Boston Scientific
,
Vivian Bishay
- 3 views
- October 19, 2020
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
FEATURING
Vivian Bishay
- 768 views
- October 19, 2020
- 2
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: How it’s Made
- 436 views
- September 16, 2020
- 5
Boston Scientific
Evolution of the HCC treatment: Optimized vs Standard Dosimetry
FEATURING
Etienne Garin
- 125 views
- September 9, 2020
Boston Scientific
Evolution of the HCC Treatment: Clinical and Dosimetric Recommendations for Y-90
FEATURING
Riad Salem,
Etienne Garin
- 414 views
- September 2, 2020
- 2
Boston Scientific
Select Locoregional therapies as a COVID-19 Risk Mitigation treatment strategy for HCC
- 162 views
- September 2, 2020
- 1
Boston Scientific
Managing Interventional Oncology in the Time of Covid-19
- 107 views
- September 2, 2020
Symposium on Clinical Interventional Oncology (CIO 2018)
M&M: Hard Lessons from the World of IO: Bad Outcomes and Whether They Could Have Been Avoided
FEATURING
Daniel Sze
- 791 views
- October 24, 2018
- 4
Symposium on Clinical Interventional Oncology (CIO 2018)
Liver Case Review: Bad Outcomes and Whether They Could Have Been Avoided
FEATURING
Sarah White
- 265 views
- October 24, 2018
Symposium on Clinical Interventional Oncology (CIO 2018)
Liver Only Metastatic Disease: Live Case Discussion
- 183 views
- October 24, 2018
Symposium on Clinical Interventional Oncology (CIO 2018)
Workout at the Y: Low Grade HCC Radioembolization Cases
FEATURING
Daniel Sze
- 332 views
- October 24, 2018
- 1
Symposium on Clinical Interventional Oncology (CIO 2018)
Workout at the Y: HCV Cirrhosis Radioembolization Case Presentation
FEATURING
Siddharth Padia
- 178 views
- October 24, 2018
- 1
Symposium on Clinical Interventional Oncology (CIO 2018)
Case Study: Metastatic Colorectal Cancer Confined to the Liver
FEATURING
Charles Ray
- 473 views
- October 24, 2018
- 3
Symposium on Clinical Interventional Oncology (CIO 2018)
Case Study: Intermediate Grade Neuroendocrine Tumor (NET)
FEATURING
Daniel Brown
- 448 views
- October 24, 2018
Symposium on Clinical Interventional Oncology (CIO 2018)
Heads Up: Red Flags and Cautions in Y90
FEATURING
Ripal Gandhi
- 973 views
- October 24, 2018
- 2
Symposium on Clinical Interventional Oncology (CIO 2018)
Dosimetry Review for the Impatient IO
FEATURING
Charles Ray
- 204 views
- October 24, 2018
- 1
Symposium on Clinical Interventional Oncology (CIO 2018)
Special Considerations in Y90: Shunts, PVT, and Non-Target Embolization Protection
FEATURING
Riad Salem
- 1,101 views
- October 24, 2018
- 8
Symposium on Clinical Interventional Oncology (CIO 2018)
The Big Picture: The Many Uses of Y90 in the Liver (and Beyond?)
FEATURING
Daniel Brown
- 303 views
- October 24, 2018
Symposium on Clinical Interventional Oncology (CIO 2018)
Weekend Update: Y90 Year in Review
FEATURING
Siddharth Padia
- 231 views
- October 24, 2018
- 1
Symposium on Clinical Interventional Oncology (CIO 2018)
Cirrhosis Case Study: Liver Radiation Lobectomy
FEATURING
Robert Lewandowski
- 688 views
- October 22, 2018
- 6
Recommended Topics:
All Topics:
Chemoembolization
Chemotherapy
Chemotherapy in Advanced Hepatocellular Cancer
Cholangiocarcinoma
Colorectal Cancer Interventions
Cryoablation for Tumors
Hepatobiliary Tumor Interventions
Irreversible Electroporation
Kidney Tumor Ablation
Liver Directed Therapy in Hepatocellular Cancer
Lung Ablation
MSK Ablation
Pancreatic Cancer Interventions
Percutaneous Nephrostomy
Prostate Cancer Interventions
Radiation Segmentectomy
Radioembolization (Y90)
Radiofrequency Ablation (RFA)
Renal Tumor
Resectable Hepatocellular Cancer